肥胖对原发性醛固酮增多症患者诊断时临床特征及术后反应的影响
基于西班牙原发性醛固酮增多症登记(SPAIN-ALDO)的回顾性研究,纳入2018至2022年20家三级中心的415例患者,其中189例(45.5%)肥胖。肥胖组代谢心血管特征更差、所需降压药更多,但血浆醛固酮浓度与肾素水平及肾上腺病变、单侧病变比例与无肥胖组相似;肥胖与肾上腺切除术后高血压治愈率较低相关。
要点
- 肥胖组糖尿病、慢性肾病、阻塞性睡眠呼吸暂停、左心室肥厚及既往心血管事件比例更高。
- 肥胖组收缩压均值更高、所需降压药更多,血糖、糖化血红蛋白、肌酐、尿酸、甘油三酯更高,高密度脂蛋白胆固醇更低。
- 两组血浆醛固酮浓度与肾素水平相似,体重指数与醛固酮或肾素无相关性;肥胖与术后高血压治愈率较低相关。
核心结论
- 原发性醛固酮增多症患者中,肥胖与更差的心血管代谢特征及需要更多降压药相关,但血浆醛固酮浓度、肾素水平、肾上腺病变率及单侧病变率与无肥胖患者相似。
- 肥胖与肾上腺切除术后高血压治愈率较低相关。
研究设计与样本
- 回顾性研究,基于西班牙原发性醛固酮增多症登记(SPAIN-ALDO Registry),纳入2018至2022年在20家三级中心就诊的原发性醛固酮增多症患者。
- 共纳入415例患者,其中189例(45.5%)为肥胖;中位年龄55岁(范围47.3-65.2岁),男性240例(58.4%)。
主要发现
- 与无肥胖患者相比,肥胖患者糖尿病、慢性肾病、阻塞性睡眠呼吸暂停综合征、左心室肥厚、既往心血管事件比例更高,收缩压均值更高,所需降压药更多。
- 肥胖患者血清葡萄糖、糖化血红蛋白A1c、肌酐、尿酸、甘油三酯更高,高密度脂蛋白胆固醇更低。
- 肥胖与无肥胖患者血浆醛固酮浓度(PAC)及肾素水平相似,体重指数与PAC及肾素均无相关性。
- 两组影像学肾上腺病变率及经肾上腺静脉取血或I-6β-碘甲基-19-去甲胆固醇闪烁显像评估的单侧病变率相似。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Patients with obesity have an overactivated renin-angiotensin-aldosterone system (RAAS) that is associated with essential hypertension. However, the influence of obesity in primary aldosteronism (PA) is unknown. OBJECTIVE: We analyzed the effect of obesity on the characteristics of PA, and the association between obesity and RAAS components. METHODS: A retrospective study was conducted of the Spanish PA Registry (SPAIN-ALDO Registry), which included patients with PA seen at 20 tertiary centers between 2018 and 2022. Differences between patients with and without obesity were analyzed. RESULTS: A total of 415 patients were included; 189 (45.5%) with obesity. Median age was 55 years (range, 47.3-65.2 years) and 240 (58.4%) were male. Compared to those without obesity, patients with obesity had higher rates of diabetes mellitus, chronic kidney disease, obstructive apnea syndrome, left ventricular hypertrophy, prior cardiovascular events, higher means of systolic blood pressure, and required more antihypertensive drugs. Patients with PA and obesity also had higher values of serum glucose, glycated hemoglobin A1c, creatinine, uric acid, and triglycerides, and lower levels of high-density lipoprotein cholesterol. Levels of blood aldosterone (PAC) and renin were similar between patients with and without obesity. Body mass index was not correlated with PAC nor renin. The rates of adrenal lesions on imaging studies, as well as the rates of unilateral disease assessed by adrenal vein sampling or I-6β-iodomethyl-19-norcholesterol scintigraphy, were similar between groups. CONCLUSION: Obesity in PA patients involves a worse cardiometabolic profile, and need for more antihypertensive drugs but similar PAC and renin levels, and rates of adrenal lesions and lateral disease than patients without obesity. However, obesity implicates a lower rate of hypertension cure after adrenalectomy.
引用
- Ruiz-Sánchez JG, Paja-Fano M, González Boillos M, et al. Effect of Obesity on Clinical Characteristics of Primary Aldosteronism Patients at Diagnosis and Postsurgical Response. J Clin Endocrinol Metab. 2023. PMID: 37428898. doi:10.1210/clinem/dgad400
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。